Korean J Nephrol.  2010 Sep;29(5):644-649.

Biopsy-Proven Immune Complex Glomerulonephritis Associated with Sunitinib in a Patient with a Gastrointestinal Stromal Tumor

Affiliations
  • 1Department of Internal Medicine, Eulji Hospital, Daejeon, Korea.
  • 2Department of Internal Medicine, Seoul National University College of Medicine, Korea. khoh@snu.ac.kr
  • 3Department of Pathology, Seoul National University College of Medicine, Korea.

Abstract

Sunitinib, a multi-targeted tyrosine kinase inhibitor, is used for the treatment of renal cell carcinoma and gastrointestinal stromal tumors. Many adverse effects associated with sunitinib, including hypertension, proteinuria, and thrombotic microangiopathy, have been reported; however, the other forms of glomerulonephritis are very rare. We report a case of biopsy-confirmed immune complex glomerulonephritis in a patient with a gastrointestinal tumor who received sunitinib treatment. The proteinuria subsided partially after sunitinib was discontinued, but when the drug was reintroduced, it recurred.

Keyword

Glomerulonephritis; Sunitinib; Gastrointestinal stromal tumor

MeSH Terms

Antigen-Antibody Complex
Carcinoma, Renal Cell
Gastrointestinal Stromal Tumors
Glomerulonephritis
Humans
Hypertension
Indoles
Protein-Tyrosine Kinases
Proteinuria
Pyrroles
Thrombotic Microangiopathies
Antigen-Antibody Complex
Indoles
Protein-Tyrosine Kinases
Pyrroles
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr